Raw Material CAS 177325-13-2 Levofloxacin HCl Powder Levofloxacin Hydrochloride

• Powder: Yes
• Customized: Customized
• Certification: ISO 9001
• Suitable for: Adult
• State: Solid
• Purity: >98%
• Model NO.: levofloxacin
• Product Name: Levofloxacin Hydrochloride
• Mf: C18h21clfn3o4
• CAS: 177325-13-2
• MOQ: 1kg
• Transport Package: Drum
• Specification: 99%
• Trademark: HS
• Origin: China
• HS Code: 2904201000
• Production Capacity: 100000

Product Description

Raw Material CAS 177325-13-2 Levofloxacin HCl Powder  Levofloxacin Hydrochloride

Product name	Levofloxacin hydrochloride
Appearance	White crystalline powder
MF	C18H21ClFN3O4
Assay	HPLC 99%
Shelf Life	2 years
Storage	Keep in cool dry place.
Other Name	(3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid monohydrochloride
cas	177325-13-2

What is Levofloxacin Hydrochloride?

Levofloxacin (Levofloxacin) is the levorotatory isomer of ofloxacin. Its water solubility is 8 times that of ofloxacin. It is easier to be made into injections and has low side effects. It was first marketed in Japan in 1994 and belongs to the third generation of quinolone antibacterial. drug. It plays an antibacterial effect mainly by inhibiting the topoisomerase IV and DNA spin Chemicalbook transase (topoisomerase ) required for bacterial DNA replication, transcription, repair and recombination. Levofloxacin is twice as active as ofloxacin against most clinical isolates. Because it has good activity against common respiratory tract pathogens Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae, it is also called "respiratory quinolone". It has stronger antibacterial activity against Pseudomonas aeruginosa.

Function of Levofloxacin Hydrochloride

This product is suitable for the following mild and moderate infections caused by sensitive bacteria;
1. Respiratory system infection: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bronchiolitis, bronchiectasis complicated infection, pneumonia, tonsillitis (peritonsillar abscess);
2. Urinary system infection: pyelonephritis, complicated urinary tract infection, etc.;
Reproductive system infections: acute prostatitis, acute epididymitis, uterine cavity infection, uterine adnexitis, pelvic inflammatory disease ;
3. Skin and soft tissue infections: infectious impetigo, cellulitis, lymphatic (nodular) inflammation, subcutaneous abscess, perianal abscess, etc.;
Intestinal infections: bacillary dysentery, infectious enteritis, Salmonella enteritis, typhoid fever and paratyphoid fever;

 

 

TEM	SPECIFICATION	METHOD REFERENCE
Appearance	white powder	Visual
Ammonium	≤200ppm	USPmonograph
Chloride	≤200ppm	USP35<221>
Sulfate	≤300ppm	USP35<221>
Iron	≤10ppm	USP35<241>
Arsenic	≤2ppm	USP35<211>
Heavy metals	≤10ppm	USP35<231>Method I
Loss on drying(3h at 105 ºC)	≤0.5%	USP35<731>
Residue on Ignition	≤0.1%	USP35<281>
Total impurities	≤2.0%	USP monograph
Assay(dry basis)	98.0% to 101.0%	USP monograph